Contemporary real-world treatment of cardiac transthyretin amyloidosis with tafamidis: a long-term multicentre study

Richard J Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voß, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister

Open source

DOI: 10.1093/eschf/xvag211
Published: 2026-07-30
Container: ESC Heart Failure
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/eschf/xvag211,
  title = {Contemporary real-world treatment of cardiac transthyretin amyloidosis with tafamidis: a long-term multicentre study},
  author = {Richard J Nies and Svenja Ney and Ingrid Kindermann and Yvonne Bewarder and Angela Zimmer and Fabian Knebel and Katrin Hahn and Sebastian Spethmann and Peter Luedike and Lars Michel and Tienush Rassaf and Maria Papathanasiou and Stefan Störk and Vladimir Cejka and Amin Polzin and Fabian Voß and Bernhard Unsöld and Christine Meindl and Michael Paulus and Ali Yilmaz and Bishwas Chamling and Caroline Morbach and Roman Pfister},
  year = {2026},
  journal = {ESC Heart Failure},
  doi = {10.1093/eschf/xvag211},
  url = {https://doi.org/10.1093/eschf/xvag211}
}

RIS

TY  - JOUR
TI  - Contemporary real-world treatment of cardiac transthyretin amyloidosis with tafamidis: a long-term multicentre study
AU  - Richard J Nies
AU  - Svenja Ney
AU  - Ingrid Kindermann
AU  - Yvonne Bewarder
AU  - Angela Zimmer
AU  - Fabian Knebel
AU  - Katrin Hahn
AU  - Sebastian Spethmann
AU  - Peter Luedike
AU  - Lars Michel
AU  - Tienush Rassaf
AU  - Maria Papathanasiou
AU  - Stefan Störk
AU  - Vladimir Cejka
AU  - Amin Polzin
AU  - Fabian Voß
AU  - Bernhard Unsöld
AU  - Christine Meindl
AU  - Michael Paulus
AU  - Ali Yilmaz
AU  - Bishwas Chamling
AU  - Caroline Morbach
AU  - Roman Pfister
PY  - 2026
JO  - ESC Heart Failure
DO  - 10.1093/eschf/xvag211
UR  - https://doi.org/10.1093/eschf/xvag211
ER  -

APA

Nies, R. J., Ney, S., Kindermann, I., Bewarder, Y., Zimmer, A., Knebel, F., Hahn, K., Spethmann, S., Luedike, P., Michel, L., Rassaf, T., Papathanasiou, M., Störk, S., Cejka, V., Polzin, A., Voß, F., Unsöld, B., Meindl, C., Paulus, M., Yilmaz, A., Chamling, B., Morbach, C., & Pfister, R. (2026). Contemporary real-world treatment of cardiac transthyretin amyloidosis with tafamidis: a long-term multicentre study. ESC Heart Failure. https://doi.org/10.1093/eschf/xvag211

Source records

crossref · retrieved 2026-09-26T15:41:11.720Z